0000885590-14-000029.txt : 20140319
0000885590-14-000029.hdr.sgml : 20140319
20140319163319
ACCESSION NUMBER: 0000885590-14-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140317
FILED AS OF DATE: 20140319
DATE AS OF CHANGE: 20140319
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chai-Onn Robert Roswell
CENTRAL INDEX KEY: 0001502213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 14704301
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
CITY: LAVAL
STATE: A8
ZIP: H7L 4A8
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-03-17
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001502213
Chai-Onn Robert Roswell
2150 ST. ELZEAR BLVD. WEST
LAVAL
A8
H7L 4A8
QUEBEC, CANADA
0
1
0
0
EVP, Gen. Couns. & Corp. Secy.
Common Stock, no par value
2014-03-17
4
M
0
5000
6.45
A
28999
D
Common Stock, no par value
2014-03-17
4
S
0
5000
141.72
D
23999
D
Non-Qualified Stock
6.45
2014-03-17
4
M
0
5000
0
D
2008-08-09
2014-08-09
Common Shares, no par value
5000
20203
D
This number represents options exercised and sold pursuant to a 10b5-1 trading plan.
This number represents the weighted average sale price for all sales of common stock sold by the reporting officer pursuant to a 10b5-1 trading plan. Actual sale executions were in the range of $141.63 and $141.80. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
The options vested one-fourth per year over four years starting from the date of grant with the first vest date falling on the first anniversary of the grant, the second vest date falling on the second anniversary of the grant, the third vest date falling on the third anniversary of the grant, and the fourth vest date falling fourth anniversary of the grant.
by: Nicholas Zanoni for Robert Chai-Onn
2014-03-19